RLAY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Relay Therapeutics Inc

Watchlist Manager

Watchlist

Price: 18.9 USD 1.34% Market Closed

Market Cap: $4.1B

	Relay Therapeutics Inc NASDAQ:RLAY	US
G	General Electric Co XMUN:GCP	US
C	CBRE Group Inc XMUN:RF6	US
M	Mondelez International Inc XHAM:KTF	US
I	Impianti SpA F:F67	IT
M	Mitsubishi Estate Co Ltd DUS:MES	JP
J	JPMorgan Chase & Co XBER:CMC	US
F	Floor & Decor Holdings Inc F:1FD	US
P	Proto Labs Inc F:PRZ	US
C	China Telecom Corp Ltd XMUN:ZCH	CN
H	Henderson Land Development Co Ltd XMUN:HLD	HK
	Primo Water Corp TSX:PRMW	US
H	Hasbro Inc XBER:HAS	US
O	Otis Worldwide Corp F:4PG	US
	ASM International NV OTC:ASMXF	NL
	Sasol Ltd NYSE:SSL	ZA

Profitability Summary

Relay Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 777%

Negative 3Y Average Operating Margin

-5 583%

Operating Margin is Increasing

-38 933% > -2 777%

Negative Net Margin

-2 554%

Negative 3Y Average Net Margin

-5 185%

Net Margin is Increasing

-36 640% > -2 554%

Negative Free Cash Flow Margin

-1 998%

Negative 3Y Average Free Cash Flow Margin

-4 007%

Free Cash Flow Margin is Increasing

-28 381% > -1 998%

Negative ROE

-40%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-543%

ROIC is Increasing

-597% > -442%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.